{
    "2019-12-11": [
        [
            {
                "time": "2023-12-16",
                "original_text": "【民生医药|周报】12/16：关注特色原料药和CXO板块，积极布局优势赛道",
                "features": {
                    "keywords": [
                        "特色原料药",
                        "CXO板块",
                        "优势赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-19",
                "original_text": "复星医药(02196)：副总裁汪曜减持股份计划期限届满且未减持A股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "副总裁",
                        "减持",
                        "未减持"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-12-19",
                "original_text": "复星医药关于高级管理人员减持股份计划期限届满的公告 拟减持股份",
                "features": {
                    "keywords": [
                        "复星医药",
                        "高级管理人员",
                        "减持",
                        "计划期限届满"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-12-19",
                "original_text": "复星医药(02196.HK)副总裁汪曜减持期届满期间未减持公司A股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "副总裁",
                        "减持期届满",
                        "未减持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-10",
                "original_text": "交银国际：中生制药开发的百西诺获颁发药品注册批件",
                "features": {
                    "keywords": [
                        "交银国际",
                        "中生制药",
                        "百西诺",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-10",
                "original_text": "智通港股通持股解析|12月10日",
                "features": {
                    "keywords": [
                        "智通港股通",
                        "持股解析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}